Stockreport

Beam Therapeutics' Q3 Earnings & Revenues Fall Shy of Estimates [Yahoo! Finance]

Beam Therapeutics Inc.  (BEAM) 
PDF The company had recorded a loss of $1.22 per share in the year-ago quarter. Total revenues, comprising license and collaboration revenues, came in at $14.3 million in [Read more]